Innovative Chromatography OraChrom specializes in high-efficiency, non-leaching stationary phases based on Poly (Styrene-divinylbenzene), making it highly attractive for biopharmaceutical companies seeking reliable purification methods to streamline production and reduce costs.

Market Niche Opportunity With a focused product portfolio featuring Simulated-Monoliths™ stationary phases, OraChrom can target pharmaceutical and biotech firms that require advanced chromatography solutions to improve yield and purity of high-value biotherapeutics.

Growing Industry Demand The biotechnology research sector continues to expand rapidly, providing a growing customer base among large and mid-sized companies utilizing chromatography for drug development, presenting significant sales potential for innovative stationary phases.

Strategic Partnership Potential Partnering with established industry players like Bio-Rad or Waters could accelerate market penetration, leveraging their extensive distribution channels and customer networks to expand OraChrom’s reach.

Technology Differentiation OraChrom's focus on durable, high-performance stationary phases positions it competitively against larger firms by emphasizing product reliability and cost-efficiency, appealing to cost-conscious R&D and manufacturing departments.